We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CHWY's Vet Care Expansion Strengthens Its High-Margin Health Business
Read MoreHide Full Article
Key Takeaways
CHWY added 10 Vet Care practices in fiscal 2025, ending the year with 18 clinics in five states.
Vet Care is becoming a key acquisition and engagement driver for high-value pet parents.
CHWY expects fiscal 2026 sales of $13.6-$13.75B, with an EBITDA margin of 6.6-6.8%.
Chewy, Inc.’s (CHWY - Free Report) continued expansion in veterinary services is reinforcing the strength of its high-margin health business and supporting long-term profitability growth. Through Chewy Vet Care (“CVC”), the company is building a differentiated pet healthcare ecosystem that extends beyond retail and deepens customer engagement.
The company opened 10 Vet Care practices in fiscal 2025, reaching the high end of its planned range and bringing its total footprint to 18 locations across five states. Management highlighted that performance continues to exceed expectations, supported by strong utilization and consistently high customer and veterinarian satisfaction scores. This strong early traction validates the scalability of the clinic model and reflects rising demand for integrated pet healthcare services.
Importantly, Vet Care is emerging as a major customer value driver. Management noted that CVC serves as both a customer acquisition engine and an engagement flywheel, helping deepen relationships with high-value pet parents. Notably, the business is now the fastest NSPAC (net sales per active customer) compounder across Chewy’s platform, underscoring its ability to drive higher customer spending and retention.
The expansion is also contributing to profitability. Chewy’s growing mix of health and wellness offerings supported gross margin expansion to 29.4% in fourth-quarter fiscal 2025, up 90 basis points year over year. Health-related services, including Vet Care, remain structurally higher-margin than the core retail business, making them a key lever for long-term earnings growth.
Looking ahead, management expects veterinary care to remain a key pillar of value creation. Chewy’s fiscal 2026 guidance of $13.6-$13.75 billion in net sales, indicating 8-9% year-over-year growth, along with the adjusted EBITDA margin guidance of 6.6-6.8%, implies continued contribution from high-margin health categories. With ongoing expansion and deeper ecosystem integration, Vet Care is poised to further enhance growth and profitability.
How Do BARK & WOOF Stack Up Against CHWY’s Margin Growth
Chewy's margin has outperformed those of its key competitors, including BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) .
BARK reported third-quarter fiscal 2026 gross profit of $61.6 million, down 22.3% year over year. The gross margin stood at 62.5% versus 62.7% in the prior-year period, with the slight decline primarily driven by revenue mix. Despite this, both DTC and Commerce gross margins improved sequentially and year over year, reflecting solid operational execution by BARK.
Petco Health and Wellness reported fourth-quarter fiscal 2025 gross profit of $581 million, down 1.4% year over year, whereas the gross margin expanded 37 basis points to 38.3%. The improvement was supported by pricing, promotional discipline and mix benefits, reflecting continued progress in profitability initiatives by Petco Health and Wellness.
CHWY’s Price Performance, Valuation & Estimates
Shares of Chewy have lost 21.2% in the past year against the industry’s growth of 6.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.79X, below the industry’s average of 1.79X. It has a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 earnings implies year-over-year growth of 27.6%, whereas the same for fiscal 2027 indicates an uptick of 23%. Estimates for fiscal 2026 and 2027 have been revised upward by 5 cents and 7 cents, respectively, in the past 30 days.
View the Zacks #1 Rank List
Image: Bigstock
CHWY's Vet Care Expansion Strengthens Its High-Margin Health Business
Key Takeaways
Chewy, Inc.’s (CHWY - Free Report) continued expansion in veterinary services is reinforcing the strength of its high-margin health business and supporting long-term profitability growth. Through Chewy Vet Care (“CVC”), the company is building a differentiated pet healthcare ecosystem that extends beyond retail and deepens customer engagement.
The company opened 10 Vet Care practices in fiscal 2025, reaching the high end of its planned range and bringing its total footprint to 18 locations across five states. Management highlighted that performance continues to exceed expectations, supported by strong utilization and consistently high customer and veterinarian satisfaction scores. This strong early traction validates the scalability of the clinic model and reflects rising demand for integrated pet healthcare services.
Importantly, Vet Care is emerging as a major customer value driver. Management noted that CVC serves as both a customer acquisition engine and an engagement flywheel, helping deepen relationships with high-value pet parents. Notably, the business is now the fastest NSPAC (net sales per active customer) compounder across Chewy’s platform, underscoring its ability to drive higher customer spending and retention.
The expansion is also contributing to profitability. Chewy’s growing mix of health and wellness offerings supported gross margin expansion to 29.4% in fourth-quarter fiscal 2025, up 90 basis points year over year. Health-related services, including Vet Care, remain structurally higher-margin than the core retail business, making them a key lever for long-term earnings growth.
Looking ahead, management expects veterinary care to remain a key pillar of value creation. Chewy’s fiscal 2026 guidance of $13.6-$13.75 billion in net sales, indicating 8-9% year-over-year growth, along with the adjusted EBITDA margin guidance of 6.6-6.8%, implies continued contribution from high-margin health categories. With ongoing expansion and deeper ecosystem integration, Vet Care is poised to further enhance growth and profitability.
How Do BARK & WOOF Stack Up Against CHWY’s Margin Growth
Chewy's margin has outperformed those of its key competitors, including BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) .
BARK reported third-quarter fiscal 2026 gross profit of $61.6 million, down 22.3% year over year. The gross margin stood at 62.5% versus 62.7% in the prior-year period, with the slight decline primarily driven by revenue mix. Despite this, both DTC and Commerce gross margins improved sequentially and year over year, reflecting solid operational execution by BARK.
Petco Health and Wellness reported fourth-quarter fiscal 2025 gross profit of $581 million, down 1.4% year over year, whereas the gross margin expanded 37 basis points to 38.3%. The improvement was supported by pricing, promotional discipline and mix benefits, reflecting continued progress in profitability initiatives by Petco Health and Wellness.
CHWY’s Price Performance, Valuation & Estimates
Shares of Chewy have lost 21.2% in the past year against the industry’s growth of 6.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.79X, below the industry’s average of 1.79X. It has a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 earnings implies year-over-year growth of 27.6%, whereas the same for fiscal 2027 indicates an uptick of 23%. Estimates for fiscal 2026 and 2027 have been revised upward by 5 cents and 7 cents, respectively, in the past 30 days.
Image Source: Zacks Investment Research
CHWY currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.